Proteins and Peptides
5 April 2016
Oramed Completes Phase IIb Oral Insulin Study4 April 2016
Motus Completes Enrollment of Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis4 April 2016
Baxalta Expands Global Reach of ADYNOVATE for Hemophilia A Patients with Approval in Japan4 April 2016
Semaglutide Demonstrated Superior Improvements in Glycemic Control vs Placebo in Adults with Type 2 Diabetes1 April 2016
Akari Therapeutics Announces Positive Preliminary Results from First PNH Patient Treated With Coversin31 March 2016
Opthea Completes Patient Enrolment for OPT-302 Phase 1 Dose Escalation Trial in Patients With Wet AMD31 March 2016
aTyr Pharma Announces Encouraging Phase 1b/2 Results for Resolaris™ in its First Rare Myopathy Trial31 March 2016
Bio Products Laboratory Receives European Approval for Coagadex® (Human Coagulation Factor X)29 March 2016
Axsome Therapeutics Initiates Phase 3 Study of AXS-02 for Knee Osteoarthritis Associated with Bone Marrow Lesions21 March 2016
XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of LupusNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports